缩写名/全名 |
ACS MED CHEM LETT
ACS Medicinal Chemistry Letters |
||||||||||||||||||||||||
ISSN号 | 1948-5875 | ||||||||||||||||||||||||
研究方向 | CHEMISTRY, MEDICINAL- | ||||||||||||||||||||||||
影响因子 | 2015:3.355, 2016:3.746, 2017:3.794, 2018:3.737, 2019:3.975, | ||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||
出版周期 | |||||||||||||||||||||||||
年文章数 | 258 | ||||||||||||||||||||||||
出版年份 | 2010 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-8周 |
||||||||||||||||||||||||
录用比例 | |||||||||||||||||||||||||
投稿链接 | https://acs.manuscriptcentral.com/acs | ||||||||||||||||||||||||
投稿官网 | http://pubs.acs.org/journal/amclct | ||||||||||||||||||||||||
h-index | 52 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1948-5875%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity. Author: Wang L1,2, Qiao GH1,2, Hu HN1, Gao ZB1, Nan FJ1. Journal: ACS Med Chem Lett. 2018 Dec 19;10(1):27-33. doi: 10.1021/acsmedchemlett.8b00315. eCollection 2019 Jan 10. PubMed DOI |
2. | Design, Synthesis, and Biological Evaluation of 6-Benzoxazole Benzimidazole Derivatives with Antihypertension Activities. Author: Wu Z1, Bao XL1, Zhu WB1, Wang YH1, Phuong Anh NT1, Wu XF2, Yan YJ2, Chen ZL1. Journal: ACS Med Chem Lett. 2018 Dec 31;10(1):40-43. doi: 10.1021/acsmedchemlett.8b00335. eCollection 2019 Jan 10. PubMed DOI |
3. | Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach. Author: Ai Y1, Obianom ON1, Kuser M1, Li Y2, Shu Y1,3, Xue F1. Journal: ACS Med Chem Lett. 2018 Dec 3;10(1):127-131. doi: 10.1021/acsmedchemlett.8b00539. eCollection 2019 Jan 10. PubMed DOI |
4. | Development of Novel Anticancer Agents with a Scaffold of Tetrahydropyrido[4,3-d]pyrimidine-2,4-dione. Author: Ma Z1, Gao G1, Fang K1, Sun H1. Journal: ACS Med Chem Lett. 2019 Jan 16;10(2):191-195. doi: 10.1021/acsmedchemlett.8b00531. eCollection 2019 Feb 14. PubMed DOI |
5. | Synthesis of 5-Thio-α-GalCer Analogues with Fluorinated Acyl Chain on Lipid Residue and Their Biological Evaluation. Author: He P1, Zhao C2, Lu J3, Zhang Y2, Fang M3, Du Y1,2,4. Journal: ACS Med Chem Lett. 2019 Jan 30;10(2):221-225. doi: 10.1021/acsmedchemlett.8b00640. eCollection 2019 Feb 14. PubMed DOI |
6. | Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents. Author: Hu X1, Wan B2, Liu Y3, Shen J1, Franzblau SG2, Zhang T3, Ding K1, Lu X1. Journal: ACS Med Chem Lett. 2019 Feb 21;10(3):295-299. doi: 10.1021/acsmedchemlett.8b00410. eCollection 2019 Mar 14. PubMed DOI |
7. | N-Benzylanilines as Fatty Acid Synthesis Inhibitors against Biofilm-related Methicillin-resistant Staphylococcus aureus. Author: Zhang J1, Huang H2, Zhou X3, Xu Y3, Chen B1, Tang W3, Xu K2. Journal: ACS Med Chem Lett. 2019 Feb 28;10(3):329-333. doi: 10.1021/acsmedchemlett.8b00612. eCollection 2019 Mar 14. PubMed DOI |
8. | Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties. Author: Zhang G1, Howe M2, Aldrich CC1,2. Journal: ACS Med Chem Lett. 2019 Feb 23;10(3):348-351. doi: 10.1021/acsmedchemlett.8b00634. eCollection 2019 Mar 14. PubMed DOI |
9. | Correction to "Synthesis of 5-Thio-α-GalCer Analogues with Fluorinated Acyl Chain on Lipid Residue and Their Biological Evaluation". Author: He P1,2, Zhao C2, Lu J3, Zhang Y2, Fang M3, Du Y1,2,4. Journal: ACS Med Chem Lett. 2019 Feb 20;10(3):394. doi: 10.1021/acsmedchemlett.9b00057. eCollection 2019 Mar 14. PubMed DOI |
10. | Contract Research Organizations Are Seeking Transformation in the Pharmaceutical Value Chain. Author: Huang J1. Journal: ACS Med Chem Lett. 2019 Mar 13;10(5):684-686. doi: 10.1021/acsmedchemlett.9b00046. eCollection 2019 May 9. PubMed DOI |
|
|